Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.

MLA

Rahman, Rifaquat, et al. “Current Drug Development and Trial Designs in Neuro-Oncology: Report from the First American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.” The Lancet. Oncology, vol. 24, no. 4, Apr. 2023, pp. e161–71. EBSCOhost, https://doi.org/10.1016/S1470-2045(23)00005-0.

APA

Rahman, R., Polley, M.-Y. C., Alder, L., Brastianos, P. K., Anders, C. K., Tawbi, H. A., Mehta, M., Wen, P. Y., Geyer, S., de Groot, J., Zadeh, G., Piantadosi, S., Galanis, E., & Khasraw, M. (2023). Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference. The Lancet. Oncology, 24(4), e161–e171. https://doi.org/10.1016/S1470-2045(23)00005-0

Chicago

Rahman, Rifaquat, Mei-Yin C Polley, Laura Alder, Priscilla K Brastianos, Carey K Anders, Hussein A Tawbi, Minesh Mehta, et al. 2023. “Current Drug Development and Trial Designs in Neuro-Oncology: Report from the First American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.” The Lancet. Oncology 24 (4): e161–71. doi:10.1016/S1470-2045(23)00005-0.